The Vanguard Mega Cap Value ETF seeks to track the performance of the CRSP US Mega Cap Value Index, a float-adjusted, market-capitalization-weighted benchmark of the largest U.S. companies that screen as value-oriented. The index selects and weights holdings using several value factors, including book-to-price, earnings-to-price, dividends-to-price, and sales-to-price ratios, which means the portfolio skews toward established, cash-generative businesses trading at relatively modest valuations.
The fund is structured as a passive index ETF and holds approximately 128 securities, with no single position exceeding roughly 5% of assets. Its ten largest holdings account for about 27% of the portfolio, a modest concentration for a mega-cap vehicle. Sector allocation is dominated by financials (about 24%), followed by healthcare (around 18%), information technology (about 16%), industrials (around 13%), and consumer staples (roughly 10%). Energy, consumer discretionary, communication services, materials, and utilities make up smaller weights. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Among its largest positions are JPMorgan Chase, Berkshire Hathaway, ExxonMobil, Micron Technology, Johnson & Johnson, Walmart, AbbVie, Costco Wholesale, Bank of America, and Cisco Systems. The fund carries a 0.05% expense ratio, among the lowest in the large-cap value category, and a 12-month trailing dividend yield near 1.9%. This broad, inexpensive, income-oriented structure helps explain the fund's comparatively stable, range-bound behavior relative to growth-tilted peers.
MGV operates at the intersection of several durable investment themes: large-cap value investing, dividend income, and defensive sector exposure. The value segment has benefited in recent years from a rotation away from high-multiple growth stocks toward companies with tangible cash flows and stronger balance sheets. Financials, the fund's largest sleeve, have been supported by a higher-for-longer interest-rate backdrop that can bolster net interest margins for banks and insurers.
Healthcare and consumer staples provide ballast through less economically sensitive earnings, while the information technology allocation—anchored in part by memory-chip maker Micron Technology—introduces a cyclical growth element to an otherwise defensive portfolio. Energy exposure through ExxonMobil and Chevron ties a portion of the fund to oil and gas price trends. The macroeconomic environment, including inflation readings, Federal Reserve policy expectations, and credit conditions, remains a key swing factor for the financial-heavy composition of the index.
Over the most recent 30-day period, MGV rose from about $162.28 to roughly $165.33, a gain of approximately 1.9%. The move was gradual rather than trend-driven, punctuated by a brief dip toward the $160 level in early October followed by a steady recovery into November. Over the trailing three-month window, the fund was essentially unchanged, slipping about 0.4% from roughly $166.04 to $165.33.
This range-bound profile is consistent with the fund's lower-beta, value-tilted construction. The broad 52-week trading range—from a low near $135.26 to a high around $169.84—underscores the fund's steady upward drift over the longer term, even as near-term price action consolidated. Strength in large banks and healthcare names has provided support, while the semiconductor holdings, led by Micron, have contributed a more volatile, cyclical influence to recent performance.
Looking ahead, several structural factors are likely to shape MGV's trajectory through 2026. Interest-rate expectations and Federal Reserve policy remain central, given the fund's heavy financials allocation; the pace and direction of any rate adjustments will influence bank profitability and insurer returns. Inflation trends and their effect on real yields will similarly matter for the value and dividend-income characteristics of the portfolio.
Earnings cycles among major holdings—particularly large banks, energy producers, and the semiconductor exposure—will drive a meaningful portion of performance. Sector rotation between value and growth styles, institutional capital flows into and out of passive value funds, and the competitive landscape among low-cost large-cap value ETFs are additional considerations. Regulatory developments affecting financials and healthcare, along with energy commodity prices, round out the key themes. While no price prediction is warranted, these factors will collectively determine whether the fund's recent consolidation gives way to renewed momentum or extended sideways trading.
In my own workflow, I frequently rely on Tickeron’s AI Screener when evaluating ETFs like this one. It lets me quickly filter thousands of securities by technical indicators, fundamentals, volatility, and AI signals to spot comparable opportunities or confirm positioning within the broader market. The platform’s ability to sort by industry and risk metrics gives a structured way to move beyond single-ticker review and identify potential additions or hedges without manual effort. For anyone looking to systematize their research, it serves as a practical starting point that integrates well with traditional analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MGV declined for three days, in 198 of 278 cases, the price declined further within the following month. The odds of a continued downward trend are 71%.
The 10-day RSI Indicator for MGV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 32 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 69 cases where MGV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MGV as a result. In 55 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for MGV turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 35 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.
MGV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
MGV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +1.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 284 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 279 of 354 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue